Blood vessel expansion action and/or from the substance which makes the substance, and the particular substance cause which possess blood platelet cohesion control action at least the medicine composition for blood vessel new life medical therapy which contains the gene which 1 where it is chosen kinds and blood vessel new life factor the cord/code is done as the active ingredient, blood vessel expansion action and/or at least it contains 1 where it is chosen kinds from the substance which makes the substance, and the particular substance cause which possess blood platelet cohesion control action, as the active ingredient the reinforcement medicine of the blood vessel new life action by the gene which blood vessel new life factor the cord/code is done and the blood vessel new life medicine which contains the purosutasaikurin synthetic enzyme gene as the active ingredient, the ets-1 gene and blood vessel new life factorThe medicine composition for blood vessel new life medical therapy which contains the other gene which the cord/code is done as the active ingredient, it contains the ets-1 gene, as the active ingredient the reinforcement medicine of the blood vessel new life action by the other gene which blood vessel new life factor the cord/code is done, and the blood vessel new life medicine which designates the ets-1 gene as the active ingredient.血管拡張作用及び/又は血小板凝集抑制作用を有する物質、及び当該物質を生じさせる物質より選ばれた少なくとも1種と、血管新生因子をコードする遺伝子とを有効成分として含有する血管新生療法用医薬組成物、血管拡張作用及び/又は血小板凝集抑制作用を有する物質、及び当該物質を生じさせる物質より選ばれた少なくとも1種を有効成分として含有する、血管新生因子をコードする遺伝子による血管新生作用の増強剤、プロスタサイクリン合成酵素遺伝子を有効成分として含有する血管新生剤、ets-1遺伝子と血管新生因子をコードする他の遺伝子とを有効成分として含有する血管新生療法用医薬組成物、ets-1遺伝子を有効成分として含有する、血管新生因子をコードする他の遺伝子による血管新生作用の増強剤、並びに、ets-1遺伝子を有効成分とする血管新生剤。
